-
Loading metrics
Imatinib Reverses Doxorubicin Resistance by Affecting Activation of STAT3-Dependent NF-κB and HSP27/p38/AKT Pathways and by Inhibiting ABCB1
- Jonathan T. Sims,
- Sourik S. Ganguly,
- Holly Bennett,
- J. Woodrow Friend,
- Jessica Tepe,
- Rina Plattner
x
- Published: January 31, 2013
- https://doi.org/10.1371/journal.pone.0055509
Viewed
Cited
Discussed
Powered by Altmetric
Questions or concerns about usage data? Please let us know.
Saved